Gastrointestinal Cancer Database (GICDB) is a repository of genetic association studies on gas
GASTROINTESTINAL (GI) cancer is common in humans.
The increasing incidence of this disease causes mortality of patients above 70 years. However, elderly patients were not older patients included in a clinical trial by Leo et al. 1 . GI cancer refers to cancer of the gastrointestinal tract (GI tract) and accessory organs of digestion (pancreas, liver and gall bladder). The symptoms are abnormal bleeding or other associated problems. It is diagnosed by endoscopy and biopsy of suspected tissue. The treatment of GI cancer is location-specific along with cancer cell type. Mortality rate is higher in cancer of GI tract and the accessory organs of digestion as compared to the cancer of any other system in the body 2, 3 . A total of 291,150 new GI cancer cases and 149,300 GI cancer deaths were projected for the United States in 2015 (ref. 4) .
Cancer is a genetic disease which is caused by certain changes in the genes which control normal cell functioning. These changes in the genes may include DNA mutation. Two major classes of genes are associated in tumour augmentation -the proto-oncogenes and tumour suppressor genes (TSGs). As a result of mutation or dysregulation, proto-oncogenes transform into oncogenes which promote abnormal cellular proliferation. TSGs regulate normal cell proliferation or mediate cell-specific differentiation. Inactivation of TSGs results in neoplastic growth. Several important genes are involved in GI carcinogenesis 5 . At present, the cancer database is available organ-wise, e.g. liver cancer 6 , cancer of pancreas 7 , esophageal cancer 8 , etc. A particular organ system accomplishes a specific task, like respiratory system for respiration, digestive system for digestion, reproductive system for reproduction, etc. It is quite obvious that there may be fundamental peculiarity and similarity in biological functioning of organ system. Similarly, disease of organ of a particular organ system must also show peculiarity and similarity in their causes, characteristics and their possible remedial measure. With the above viewpoint in view, the gastrointestinal cancer database (GICDB) has been developed. This is a comprehensive oncogenomic database of GI cancer. It integrates information on protein coding genes, miRNAs, gene ontology, drug and drug targets and on plants with medicinal values that are utilized in the treatment of several types of GI cancer.
Description and construction of the database
GICDB consists of information on genes involved in various GI cancers, identified from the published literature. PubMed has been queried using different keywords like gastric carcinoma, esophageal cancer, hepatocellular carcinoma, etc. and abstracts were retrieved. These PubMed-indexed articles were studied by biologists to identify the genes responsible for GI cancers. Then generelated information such as gene name, gene id, chromosome location, etc. was retrieved from various sources like Entrez Gene 9 , GeneCards 10 and OMIM 11 (Online Mendelian Inheritance in Man, 2007). miRNAs play an important role during the regulation of most pathways, although changes in the expression of miRNAs are connected with many pathologies of humans including cancer. When TSGs and oncogenes are being targeted, the key cellular process which determines the cell phenotype has been modulated by miRNAs 12 . After key modulation, cell phenotype may be the potential therapeutic target. GICDB includes information on miRNA misregulation in GI cancer identified from the published literature.
Drug-related information has also been included in this database, obtained from DrugBank 13 . It provides chemical and pharmacological properties of drugs, drug targets, coordinate files for proteins and links of databases such as RxList (http://www.rxlist.com/script/main/hp.asp) 14 , KEGG drug (http://www.genome.jp/kegg/drug/) 15 15 and PharmGKB (http://www. pharmgkb.org/) 17 . Information on plants with medicinal value used in the treatment of different GI cancers is also included in the database. Allopathic system of medicine is associated with side effects, high cost and resistance developed against the recently used drugs. This has encouraged the utilization of plant products for various human diseases. Due to their efficacy and less side effects, herbal medicines have drawn attention of scientists to use plant products for the treatment of a variety of human ailments, including cancer 18 . The GICDB database has been built in ASP and information translated into MySQL database management system, which works at the backend of the database. Web interface was designed by HTML, Java script and CSS 19 . Currently, information on 463 genes and 713 miRNA genes is available in the database (Figure 1 ).
Data access
The web interface query form of GICDB (http://gidb. subdic-bioinformatics-nitrr.in) permits researchers to search the desired genes and proteins from the database. A list of genes is retrieved and these genes are further linked with specific details. The initial page of every gene contains the following details: (i) specific information of gene with symbol, id of gene, gene name, gene aliases, contig, chromosome location; (ii) link to other public databases, HGNC id, GeneBank id, UniGene id, HPRD id, Ensemble id; (iii) clicking on gene product provides information related to CDS, mRNA and protein sequence, UniProt id and PDB id details; (iv) link to associated disease; (v) link to homologous gene entries, and (vi) linking the reference for confirmation that the gene belongs to a particular GI cancer. Information on miRNAs can be search in a similar manner. Then, link to miRBase is provided from the miRNAs (Figure 2) 20 . 
Analysis and significance of GICDB
GICDB is not a substitute for the currently available resources. It serves as complementary information to the already available resources. Data in GICDB are manually curated by biologists along with link to information from other resources. Gene-related information includes Entrez gene id, chromosome location, nucleotide sequence, protein sequence and PubMed literature id, which illustrates the involvement of genes in GI cancer. This database is useful for researchers to compare the genes systematically and provide information on distinctive genes and demonstrate the abnormal characteristics in various GI cancers. One of the unique features of GICDB is that it includes information on drugs related to GI cancers from DrugBank. It contains modes of action, plasma protein-binding percentage, pharmacological properties, structural properties and chemical properties of each drug molecule. It also provides absorption, distribution, metabolism, excretion and toxicity (ADMET) properties of compounds that are important for new drug development. This drugrelated information will help researchers and clinicians in the discovery of targets for new drugs, computational designing of drugs, in silico docking of drugs, and identification of ADMET properties of concordants of these drugs molecules 21 . Scientists are exploring new anticancer compounds from plants to reduce undesirable side effects associated with chemotherapy drugs. Hence GICDB includes information on medicinal plants with the structure of their active constituents. These data may be helpful for researchers to further explore the medicinal value of these plants. This may lead to the discovery of potential anticancer drugs 22 . Going through above database, it has been observed that EGFR, GSTP1, GSTT1, MTHFR, ABCB1 genes are common among various GI cancers. These genes may serves as targets for pharmacogenomics in GI cancer. Similar in-depth efforts from the community of researchers in this area can be initiated and explored. The outcome of systematic research is expected to open new ventures towards identification, diagnosis and therapeutic measures for GI cancer.
Conclusion
GICDB is an integrated-type panoptic database. Information on drugs and drug targets helps identify new targets for future evaluation. This database may serve as a repository for GI cancer providing important information for researchers and clinicians working in this field. It would significantly save time and effort of researchers to retrieve information on genes involved in GI cancer and helps in answering pertinent biological questions involving GI cancer.
